The estimated Net Worth of Dennis Carson is at least 4.64 百万$ dollars as of 28 March 2006. Dennis Carson owns over 12,000 units of Dynavax Technologies stock worth over 3,907,078$ and over the last 20 years Dennis sold DVAX stock worth over 730,800$.
Dennis has made over 6 trades of the Dynavax Technologies stock since 2004, according to the Form 4 filled with the SEC. Most recently Dennis sold 12,000 units of DVAX stock worth 78,000$ on 28 March 2006.
The largest trade Dennis's ever made was selling 50,000 units of Dynavax Technologies stock on 13 December 2004 worth over 381,500$. On average, Dennis trades about 2,488 units every 11 days since 2004. As of 28 March 2006 Dennis still owns at least 358,119 units of Dynavax Technologies stock.
You can see the complete history of Dennis Carson stock trades at the bottom of the page.
Dennis's mailing address filed with the SEC is C/O MOORES UCSD CANCER CENTER, UCSD, 9500 GILLMAN DRIVE, LA JOLLA, CA, 92093.
Over the last 21 years, insiders at Dynavax Technologies have traded over 196,839,440$ worth of Dynavax Technologies stock and bought 2,463,112 units worth 11,318,051$ . The most active insiders traders include Andrew A. F. Hack、Partners L P/Ilbiotechnolog...、James Edeerfield Capital Lp.... On average, Dynavax Technologies executives and independent directors trade stock every 43 days with the average trade being worth of 1,533,390$. The most recent stock trade was executed by Francis Cano on 31 May 2024, trading 3,615 units of DVAX stock currently worth 43,127$.
dynavax technologies corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. our clinical-stage product candidates include: phase 3 heplisav-b ™ adult hepatitis b vaccine phase 1/2 cancer immunotherapy phase 2 asthma therapy - partnered with astrazeneca in europe, dynavax manufactures hepatitis b surface antigen for heplisav-b.
Dynavax Technologies executives and other stock owners filed with the SEC include: